阵发性睡眠性血红蛋白尿发病机制的研究进展
被引量:2
摘要
阵发性睡眠性血红蛋白尿(paroxysmal nocturnal hemoglobinuria,PNH)是一种获得性造血干细胞疾病,目前学者们基本认同PNH发病的“双发病机制”说,即磷脂酰肌醇聚糖A基因突变致糖基磷脂酰肌醇锚链蛋白缺乏以及PNH异常造血干细胞的克隆扩增。但目前为止,其确切的发病机制仍不清楚。
出处
《国际输血及血液学杂志》
CAS
2010年第3期271-274,共4页
International Journal of Blood Transfusion and Hematology
参考文献38
-
1韩冰(综述),赵永强(审校).阵发性睡眠性血红蛋白尿症研究进展[J].国际输血及血液学杂志,2009(6):497-500. 被引量:3
-
2Miyata T,Takeda J,Iida Y,et al.The cloning of PIG-A,a component in the early step of GPI-anchor biosynthesis.Science,1993,259(5099):1318-1320.
-
3Takeda J,Miyata T,Kawagoe K,et al.Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.Cell,1993,73(4):703-711.
-
4Nishimura J,Inoue N,wada H,et al.A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones.Blood,1997,89(9):3470-3476.
-
5Brodsky RA,Hu R.PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis.Leuk Lymphoma,2006,47(7):1215-1221.
-
6Araten DJ,Luzzatto L.The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria(PNH).Blood,2006,108(2):734-736.
-
7Boccuni P,Del Vecchio L,Di Noto R,et al.Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.Crit Rev Oncol Hematol,2000,33(1):25-43.
-
8Ruiz-Delgado GJ,Vazquez-Garza E,Mendez-Ramirez N,et al.Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.Hematology,2009,14(1):33-37.
-
9Hillmen P,Young NS,Schubert J,et al.The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.N Engl J Med,2006,355(12):1233-1243.
-
10Hillmen P,Muus P,Duhrsen U,et al.Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.Blood,2007,110(12):4123-4128.
二级参考文献23
-
1钟玉萍,武永吉,沈悌,汪玄,张洁萍.裸鼠腹腔输注体外扩增的阵发性睡眠性血红蛋白尿症病人骨髓CD34^+CD59^+细胞的研究[J].中国实验血液学杂志,2006,14(1):75-78. 被引量:4
-
2Araten DJ, Nafa K, Pakdeesuwan K, et al. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A,1999,96(9):5209-5214.
-
3Keller P, Payne JL, Tremml G, et al. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med, 2001, 194(5) :581-589.
-
4Horikawa K, Kawaguchi T, Ishihara S, et al. Frequent detection of T cells with mutations of the hypoxanthine guanine phosphoribosyl transferase gene in patients with PNH. Blood, 2002,99(1) :24-29.
-
5Karadimitris A, Manavalan JS, Thalcr HT. et al. Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood, 2000,96(7) :2613-2620.
-
6Brodsky RA, Vala MS, Barber JP, et al. Resistance to apoptosis caused by PIG A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A, 1997,94 (16) : 8756-8760.
-
7Ware RE, Nishimura J, Moody MA, et al. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria. Blood,1998,92(7) :2541-2550.
-
8Brodsky RA, Hu R. PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis. Leuk Lymphoma, 2006,47(7) : 1215-221.
-
9Hall C, Riehards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood,2003,102(10) :3587-3591.
-
10Moyo VM, Mukhina GL, Garrett ES, et al. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol, 2004,126(1):133-138.
同被引文献9
-
1贾巧云,程艳霞,李宏军,王晓霞,史银成.MA方案与PAC方案治疗难治性或复发性PNH疗效分析[J].邯郸医学高等专科学校学报,2005,18(5):504-505. 被引量:2
-
2丁磊.CD55/CD59在白血病中的表达及意义[J].上海交通大学,2009,32(1):68-70.
-
3许多荣,邹外一,张祥忠,黄珊.非清髓性异基因造血干细胞移植治疗难治性阵发性睡眠性血红蛋白尿症四例[J].中华器官移植杂志,2009,30(4):248-248. 被引量:7
-
4张彦,黄平平,李尚珠,韩忠朝.血清叶酸、维生素B12及铁蛋白在四种血液病演变中的意义[J].中国综合临床,2010,26(6):585-588. 被引量:7
-
5汪丹,付蓉,邵宗鸿.阵发性睡眠性血红蛋白尿症患者正常与异常克隆血细胞膜蛋白差异表达研究进展[J].中华血液学杂志,2011,32(1):68-70. 被引量:2
-
6冯祥艳,葛美丽,郑以州.阵发性睡眠性血红蛋白尿症靶向治疗策略[J].中华血液学杂志,2011,32(9):638-641. 被引量:4
-
7邹农,韩冰,蔡昊,许莹,汪玄,李蓉生,沈悌.76例阵发性睡眠性血红蛋白尿症患者临床特点分析[J].中华血液学杂志,2012,33(6):471-474. 被引量:12
-
8邵宗鸿,赵明峰,李克,刘鸿,张益枝,施均,何广胜,和虹,张泓,陈桂彬,储榆林,杨天楹.低剂量联合化疗对难治性、复发性阵发性睡眠性血红蛋白尿症的疗效观察[J].中国实用内科杂志,2000,20(10):607-609. 被引量:13
-
9颜成晋,杨可心.低剂量MP方案对19例难治性阵发性睡眠性血红蛋白尿症的疗效观察[J].临床医药实践,2004,13(2):112-113. 被引量:1
-
1尹大龙,刘连新,张树庚,姜洪池.阵发性睡眠性血红蛋白尿继发门静脉高压症致上消化道出血一例[J].中华普通外科杂志,2007,22(8):622-622.
-
2徐伟来,陈志妹,金洁,楼基余,俞运彪.76例骨髓增生异常综合征患者的细胞遗传学分析[J].中华血液学杂志,2003,24(3):152-153. 被引量:2
-
3柴俊月,郑雯琦,黄晓军.70岁以上老年人骨髓增生异常综合征21例临床分析[J].临床血液学杂志,2004,17(4):233-234. 被引量:2
-
4茅国群,陈晓亮.2型糖尿病合并冠心病患者冠脉CTA所见与中医证型特点分析[J].浙江中医杂志,2010,45(5):323-324. 被引量:5
-
5贾民勇,许志强,山小薪,傅玉琼,湛晓勤.露聚糖肽对结核性胸膜炎患者胸水中INF-γ、IL-4表达的影响[J].国际呼吸杂志,2012,32(23):1765-1767.
-
6高宏,王海强.结缔组织细胞外基质的组织化学和免疫组织化学[J].国外医学(创伤与外科基本问题分册),2000,21(2):80-82. 被引量:1
-
7许先兴,杨静文,卢学春,刘丽宏.阵发性睡眠性血红蛋白尿发病机制与诊治模式的研究进展[J].中国实验血液学杂志,2013,21(2):530-535. 被引量:8
-
8王树叶,王巍,周晋,王卓如.阵发性睡眠性血红蛋白尿患者红细胞及血浆中乙酰胆碱酯酶的测定[J].中国实用内科杂志,2007,27(24):1958-1959. 被引量:1
-
9张敏.老年骨髓增生异常综合征20例临床分析[J].中国乡村医药,2008,15(2):26-26.
-
10韩冰,赵永强.阵发性睡眠性血红蛋白尿症与血栓形成关系的认识[J].诊断学理论与实践,2008,7(5):467-469. 被引量:1